These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effect of tetrandrine on myocardial Na+, K(+)-ATPase in renovascular hypertensive rats.
    Author: Chen NH, Wang YL, Ding JH.
    Journal: Zhongguo Yao Li Xue Bao; 1991 Nov; 12(6):488-93. PubMed ID: 1668564.
    Abstract:
    In renovascular hypertensive rats (RVHR, two-kidney, one-clip model), the myocardial Na+, K(+)-ATPase showed a reduced activity. Though its sensitivities to K+ and ouabain (Oua) were not changed, the enzyme was less responsive to Na+ and ATP, and also much more susceptible to the inhibitory effect of Ca2+. Tetrandrine (Tet, ig 50 mg.kg-1, qd x 26 d) increased the myocardial Na+, K(+)-ATPase activity in RVHR. However, in vitro, Tet elevated moderately the enzyme activity in RVHR only at high concentrations (100-1,000 mumol.L-1), and failed to influence the enzyme activity in normotensive rats. In RVHR, treatment by Tet in vivo increased the degree of the Na+, K(+)-ATPase activation under suboptimal substrate (Na+, K+, or ATP) concentrations and antagonized the inhibitory effect of Ca2+ or Oua. Similar results were found when the enzyme preparation from RVHR was incubated with Tet 10 mumol.L-1 during ATPase analysis. On the contrary, the myocardial Mg(2+)-ATPase activity was higher in RVHR. Tet depressed this enzyme both in vivo and in vitro. These facts indicate that the increased myocardial Na+, K(+)-ATPase activity in RVHR is not only secondary to the calcium channel blocking or antihypertensive action of Tet but also due to its direct effects on the Na+, K(+)-ATPase and Mg(2+)-ATPase.
    [Abstract] [Full Text] [Related] [New Search]